Zealand Pharma Statistics

Total Valuation

Zealand Pharma has a market cap or net worth of GBP 2.88 billion. The enterprise value is 1.95 billion.

Market Cap	2.88B
Enterprise Value	1.95B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	70.99M
Shares Outstanding	n/a
Shares Change (YoY)	+16.16%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	60.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	3.95
PS Ratio	461.58
PB Ratio	3.09
P/TBV Ratio	3.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.67
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.25

Financial Position

The company has a current ratio of 25.10, with a Debt / Equity ratio of 0.05.

Current Ratio	25.10
Quick Ratio	24.39
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.32
Interest Coverage	-40.02

Financial Efficiency

Return on equity (ROE) is -21.27% and return on invested capital (ROIC) is -14.88%.

Return on Equity (ROE)	-21.27%
Return on Assets (ROA)	-13.97%
Return on Invested Capital (ROIC)	-14.88%
Return on Capital Employed (ROCE)	-16.20%
Revenue Per Employee	16,223
Profits Per Employee	-345,322
Employee Count	335
Asset Turnover	0.01
Inventory Turnover	0.03

Taxes

Income Tax	-520,459
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-51.54%
50-Day Moving Average	433.05
200-Day Moving Average	663.05
Relative Strength Index (RSI)	35.28
Average Volume (20 Days)	31,351

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zealand Pharma had revenue of GBP 6.25 million and -132.95 million in losses. Loss per share was -1.94.

Revenue	6.25M
Gross Profit	5.83M
Operating Income	-159.27M
Pretax Income	-133.47M
Net Income	-132.95M
EBITDA	-158.16M
EBIT	-159.27M
Loss Per Share	-1.94

Full Income Statement

Balance Sheet

The company has 958.21 million in cash and 44.26 million in debt, giving a net cash position of 913.95 million.

Cash & Cash Equivalents	958.21M
Total Debt	44.26M
Net Cash	913.95M
Net Cash Per Share	n/a
Equity (Book Value)	931.74M
Book Value Per Share	13.18
Working Capital	964.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -135.46 million and capital expenditures -1.46 million, giving a free cash flow of -136.92 million.

Operating Cash Flow	-135.46M
Capital Expenditures	-1.46M
Free Cash Flow	-136.92M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	93.39%
Operating Margin	-2,550.13%
Pretax Margin	-2,136.97%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zealand Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.16%
Shareholder Yield	n/a
Earnings Yield	-4.61%
FCF Yield	-4.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Zealand Pharma has an Altman Z-Score of 37.79 and a Piotroski F-Score of 1.

Altman Z-Score	37.79
Piotroski F-Score	1